Covid-19 y su repercusión en las adicciones

  1. Sixto Costoya, Andrea 1
  2. Lucas Domínguez, Rut 2
  3. Agulló Calatayud, Víctor 3
  1. 1 Unidad de Investigación Social y Sanitaria UISYS (CSIC-Universitat de València) y Departamento de Historia de la Ciencia y Documentación. Facultad de Medicina, Universitat de València, España,
  2. 2 Unidad de Investigación Social y Sanitaria UISYS (CSIC-Universitat de València), Departamento de Historia de la Ciencia y Documentación. Facultad de Medicina, Universitat de València, España y CIBERONC, España,
  3. 3 Unidad de Investigación Social y Sanitaria UISYS (CSIC-Universitat de València) y Departamento de Sociología y Antropología Social. Facultad de Ciencias Sociales, Universitat de València, España
Mostrar afiliaciones +
Revista:
Health and addictions: salud y drogas

ISSN: 1578-5319

Año de publicación: 2021

Volumen: 21

Número: 1

Páginas: 259-278

Tipo: Artículo

DOI: 10.21134/HAAJ.V21I1.582 DIALNET GOOGLE SCHOLAR lock_openAcceso abierto editor

Otras publicaciones en: Health and addictions: salud y drogas

Resumen

Objetivo. Indagar acerca de la literatura científica emergente a nivel internacional sobre la repercusión de la pandemia por COVID-19 en las adicciones. Metodología. La base de datos Web of Science se utilizó para analizar la literatura científica sobre la pandemia por COVID-19 y la influencia que ésta pueda tener en el ámbito de las adicciones. Resultados. Se identificaron 320 documentos, de los cuales 38 cumplieron los criterios de inclusión. Sobresalieron tres problemáticas: el consumo de tabaco, opioides y alcohol. Según la literatura incipiente, entre los consumidores de opiáceos existe el riesgo de aumento de las sobredosis, así como un empeoramiento del binomio estrés-alcohol y un peor pronóstico de la enfermedad COVID-19 para los fumadores de tabaco. Destaca la preocupación por la disminución de servicios sanitarios focalizados en las adicciones y la salud mental. Conclusiones. La literatura es muy reciente y es necesaria más evidencia científica que arroje luz. Se pone de manifiesto la preocupación por el alcohol, opioides y tabaco, pero se constata la escasez de referencias a adicciones sin sustancia (nuevas tecnologías, juego online) o a los hipnóticos y las benzodiacepinas.

Referencias bibliográficas

  • Ahmed, M. Z., Ahmed, O., Aibao, Z., Hanbin, S., Siyu, L., Ahmad, A. (2020). Epidemic of COVID-19 in China and associated Psychological Problems. Asian Journal of Psychiatry, 51, 102092.
  • Alexander, G. C., Stoller, K. B., Haffajee, R. L., Saloner, B. (2020). An Epidemic in the Midst of a Pandemic: Opioid Use Disorder and COVID-19. Annals of Internal Medicine, 19–21.
  • Arya, S., Gupta, R. (2020). COVID-19 outbreak: Challenges for Addiction services in India. Asian Journal of Psychiatry, 51(March), 102086.
  • Bansal, P., Bingemann, T. A., Greenhawt, M., Mosnaim, G., Nanda, A., Oppenheimer, J.,Shaker, M. (2020). Clinician Wellness During the COVID-19 Pandemic: Extraordinary Times and Unusual Challenges for the Allergist/Immunologist. The Journal of Allergy and Clinical Immunology: In Practice, 8(6), 1781-1790.e3.
  • Becker, W., Fiellin, D. (2020). When Epidemics Collide: Coronavirus Disease 2019 (COVID-19) and the Opioid Crisis William. Annals of Internal Medicine, 1–3.
  • Brake, S. J., Barnsley, K., Lu, W., McAlinden, K. D., Eapen, M. S., Sohal, S. S. (2020). Smoking Upregulates Angiotensin Converting Enzyme-2 Receptor: A Potential Adhesion Site for Novel Coronavirus SARS-CoV-2 (Covid-19). Journal of Clinical Medicine, 9(3), 841.
  • Cai, G., Bossé, Y., Xiao, F., Kheradmand, F. (2020). Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2. American Journal of Respiratory and Critical Care Medicine, 201(12), 1–11.
  • Carrico, A. W., Horvath, K. J., Grov, C., Moskowitz, J. T., Pahwa, S., Pallikkuth, S., Hirshfield, S. (2020). Double Jeopardy: Methamphetamine Use and HIV as Risk Factors for COVID-19. AIDS and Behavior, (0123456789), 1–4.
  • Clay, J. M., Parker, M. O. (2020). Alcohol use and misuse during the COVID-19 pandemic: a potential public health crisis? The Lancet Public Health, 5(5), 30088–8.
  • da Silva, A. C. L., Martelli, H., Ferreti, P. R., Kowalskie, L. P., da Cruz, D. E. (2020). COVID-19, head and neck cancer, and the need of training of health students and practitioners regarding to tobacco control and patient counseling. Oral Oncology, 106.
  • Dunlop, A., Lokuge, B., Masters, D., Sequeira, M., Saul, P., Dunlop, G.,Maher, L. (2020). Challenges in maintaining treatment services for people who use drugs during the COVID-19 pandemic. Harm Reduction Journal, 17(26).
  • Editorial. (2020). The COVID-19 pandemic and mental health impacts. International Journal of Mental Health Nursing, 29, 315-318.
  • García, L., de la Fuente, L., Sáiz, P. A., García, M. P., & Bobes, J. (2020). ¿Se observarán cambios en el consumo de alcohol y tabaco durante el confinamiento por COVID-19? Adicciones, 32(2), 85–89.
  • Gurmeet, A., Mds, S., Surgery, M., Glasgow, M. (2020). Tobacco use and vaping in the COVID-19 era. Head & Neck, 42(6), 1–3.
  • Hefler, M., Gartner, C. E. (2020). The tobacco industry in the time of COVID-19: time to shut it down? Tobacco Control, 29(3), 245-246.
  • Jenkins, W. D., Bolinski, R., Bresett, J., Ham, B. V., Fletcher, S., Walters, S., Ouellet, L. (2020). COVID-19 During the Opioid Epidemic – Exacerbation of Stigma and Vulnerabilities. The Journal of Rural Health, (March), 1–3.
  • Kar, S. K., Arafat, S. M. Y., Sharma, P., Dixit, A., Marthoenis, M., Kabir, R. (2020). COVID-19 pandemic and addiction: Current problems and future concerns. Asian Journal of Psychiatry, 51.
  • Kaur, J.,Rinkoo, A. V. (2020). Public health perspectives of smokeless tobacco and areca nut use in the COVID-19 era. Nicotine & Tobacco Research, xx(xx) 1–2.
  • King, D. L., Delfabbro, P. H., Billieux, J., Potenza, M. N. (2020). Problematic online gaming and the COVID-19 pandemic. Journal of Behavioral Addictions, 9(2), 184-186.
  • Lazcano, E., Alpuche, C. (2020). Alfabetización en salud pública ante la emergencia de la pandemia por Covid-19. Salud Pública de México, 62(3), 331–340.
  • Lee, S. A. (2020). Coronavirus anxiety scale: A brief mental health screener for COVID-19 related anxiety. Death Studies, 44(7), 393-401.
  • Lima, N. N. R., de Souza, R. I., Gomes, P. W., de Sousa, J. L., Lima da Silva, C. G.,Neto, M. L. R. (2020). People experiencing homelessness: Their potential exposure to COVID-19. Psychiatry Research, 288, 1-2.
  • Lippi, G., Henry, B. M., Bovo, C., Sanchis, F. (2020). Health risks and potential remedies during prolonged lockdowns for coronavirus disease 2019 (COVID-19). Diagnosis, 7(2), 85-90.
  • Liu, J. J., Bao, Y., Huang, X., Shi, J., Lu, L. (2020). Mental health considerations for children quarantined because of COVID-19. The Lancet Child & Adolescent Health, 4(5), 347-349.
  • Marsden, J., Darke, S., Hall, W., Hickman, M., Holmes, J., Humphreys, K.,West, R. (2020). Mitigating and learning from the impact of COVID-19 infection on addictive disorders. Addiction, 115(6), 1007-1010.
  • Olds, J. L., Kabbani, N. (2020). Is nicotine exposure linked to cardiopulmonary vulnerability to COVID-19 in the general population? The FEBS Journal, 1–5.
  • Reece, A. S.,Hulse, G. (2020). America Addresses Two Epidemics – Cannabis and Coronavirus and their Interactions: An Ecological Geospatial Study. Journal: BMJ Open, 1-58.
  • Reynolds, J., Wilkinson, C. (2020). Accessibility of ‘essential’ alcohol in the time of COVID-19: Casting light on the blind spots of licensing? Drug and Alcohol Review, 39(4), 7–10.
  • Russo, P., Bonassi, S., Giacconi, R., Malavolta, M., Tomino, C., Maggi, F. (2020). Early View COVID-19 and Smoking. Is Nicotine the Hidden Link? European Respiratory Journal.
  • Sani, G., Janiri, D., Di Nicola, M., Janiri, L., Ferretti, S., Chieffo, D. (2020). Mental health during and after the COVID-19 emergency in Italy. Psychiatry and Clinical Neurosciences, 74(6), 372-373.
  • Satre, D. D., Hirschtritt, M. E., Silverberg, M. J., Sterling, S. A. (2020). Addressing problems with alcohol and other substances among older adults during the COVID-19 pandemic. The American Journal of Geriatric Psychiatry, (28)7, 780-783.
  • Sexton, M. (2020). Cannabis in the Time of Coronavirus Disease 2019: The Yin and Yang of the Endocannabinoid System in Immunocompetence. The Journal of Alternative and Complementary Medicine, 26(6), 444-448.
  • Shalbafan, M., Khademoreza, N. (2020). What we can learn from COVID-19 outbreak in Iran about the importance of alcohol use education. The American Journal of Drug and Alcohol Abuse, 46(3), 1–2.
  • Tindle, H. A., Newhouse, P. A., Freiberg, M. S. (2020). Beyond Smoking Cessation: Investigating Medicinal Nicotine to Prevent and Treat COVID-19. Nicotine & Tobacco Research : Official Journal of the Society for Research on Nicotine and Tobacco, xx(xx), 1–2.
  • Tsai, J., Wilson, M. (2020). COVID-19: a potential public health problem for homeless populations. The Lancet Public Health, 5(4), e186–e187.
  • Usher, K., Bhullar, N., Jackson, D. (2020). Life in the pandemic: Social isolation and mental health. Journal of Clinical Nursing, 29(15-16), 2756-2757.
  • Vázquez, J., Redolar Ripoll, D. (2020). COVID-19 outbreak impact in Spain: A role for tobacco smoking? Tobacco Induced Diseases, 18, 1–2.
  • Vecchio, S., Ramella, R., Drago, A., Carraro, D., Littlewood, R., Somaini, L. (2020). COVID19 pandemic and people with opioid use disorder: innovation to reduce risk. Psychiatry Research, 289, 113047, 1-2.
  • Volkow, N. D. (2020). Collision of the COVID-19 and Addiction Epidemics. Annals of Internal Medicine, 173(1), 61-62.
  • Wakeman, S. E., Green, T. C., Rich, J. (n.d.). An overdose surge will compound the COVID-19 pandemic if urgent action is not taken. Nature Medicine, 26, 819-820.
  • Wilson, C. G., Ramage, M., Fagan, E. B. (2020). A Primary Care Response to COVID-19 for Patients with an Opioid Use Disorder. The Journal of Rural Health, 1-3.
  • Yang, Y., Li, W., Zhang, Q., Zhang, L., Cheung, T., Xiang, Y. T. (2020). Mental health services for older adults in China during the COVID-19 outbreak. The Lancet Psychiatry, 7(4), e19.
Fuente de los datos: Dialnet